What happens when electric utility monopolies pursue their acquisition interests—undisciplined by competition, and insufficiently disciplined by the regulators responsible for replicating competition? Since the mid-1980s, mergers and acquisitions of U.S. electric utilities have halved the number of local, independent utilities. Mostly debt-financed, these transactions have converted retiree-suitable investments into subsidiaries of geographically scattered conglomerates. Written by one of the U.S.’s leading regulatory thinkers, this book combines legal, accounting, economic and financial analysis of the 30-year march of U.S. electricity mergers with insights from the dynamic field of behavioral economics.
What happens when electric utility monopolies pursue their acquisition interests—undisciplined by competition, and insufficiently disciplined by the regulators responsible for replicating competition? Since the mid-1980s, mergers and acquisitions of U.S. electric utilities have halved the number of local, independent utilities. Mostly debt-financed, these transactions have converted retiree-suitable investments into subsidiaries of geographically scattered conglomerates. Written by one of the U.S.’s leading regulatory thinkers, this book combines legal, accounting, economic and financial analysis of the 30-year march of U.S. electricity mergers with insights from the dynamic field of behavioral economics.
The most readable, most comprehensive book in its field, Clinical Gynecologic Oncology, 9th Edition is the leading reference for diagnosis and treatment of gynecologic cancers – a must-have reference for improving outcomes and providing effective care. A "who’s who" list of contributing authors, under the editorial direction of Drs. Philip DiSaia and William Creasman, provides expert guidance on clinical presentations and management, now fully up to date with a brand-new design for faster, easier reference. Contains useful appendices covering staging, screening, nutritional therapy, toxicity criteria, blood component therapy, and radiation therapy. Covers hot topics such as multi-panel genetic testing, target therapies, sentinel node concept in endometrial cancer and vulvar cancer, and robotic surgery. Updates include new quick-reference features such as key point boxes with bulleted lists, highlighted key text, enhanced chapter outlines, and a brand-new design throughout. Includes up-to-date references and algorithms, making this text a comprehensive resource for clinical practice, personal study, and exam review. Helps you take advantage of the latest advances in early detection and improved treatment options for gynecologic cancers, especially uterine and cervical cancers.
Das Handbuch stellt gewöhnliche ebenso wie spezielle Probleme in der gynäkologischen Klinik in Form evidenzbasierter Behandlungsformen dar und benennt die diagnostischen und therapeutischen Möglichkeiten, die heute zur Verfügung stehen. Datenerhebung, Entscheidungsanalyse, Kosten und Ergebnisse sind die Prozessstufen, die detailliert dargestellt werden. Jedes Kapitel beginnt mit einem klinischen Profil der Krankheit bzw. Beschwerde und stellt eine Methodologie vor, die auf Daten datenbasierende Entscheidungsanalysen verwendet, um schließlich zu einer Behandlungsempfehlung zu gelangen. Ein "Entscheidungs-Baum" führt Faktoren wie Behandlungsoptionen, erwartete Ergebnisse und Kosten zusammen. Evidenzgrade und Levels werden im Layout unterschiedlich dargestellt und helfen bei der Orientierung. Mit diesem Band liegt das erste konsequent evidenzbasierte Werk zur perioperativen und unterstützenden Versorgung in der gynäkologischen Onkologie vor.
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.